PHARMA
Quarterly rpt on consolidated results for the financial period ended 31 Dec 2019
PHARMANIAGA BERHAD |
Financial Year End | 31 Dec 2019 |
Quarter | 4 Qtr |
Quarterly report for the financial period ended | 31 Dec 2019 |
The figures | have not been audited |
Remarks : |
- |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
31 Dec 2019
|
31 Dec 2018
|
31 Dec 2019
|
31 Dec 2018
|
||
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
1 | Revenue |
715,683
|
596,644
|
2,820,530
|
2,384,956
|
2 | Profit/(loss) before tax |
-238,474
|
11,940
|
-191,865
|
70,220
|
3 | Profit/(loss) for the period |
-178,733
|
4,570
|
-149,447
|
43,230
|
4 | Profit/(loss) attributable to ordinary equity holders of the parent |
-178,598
|
4,437
|
-149,219
|
42,468
|
5 | Basic earnings/(loss) per share (Subunit) |
-68.45
|
1.71
|
-57.19
|
16.33
|
6 | Proposed/Declared dividend per share (Subunit) |
0.00
|
2.00
|
8.50
|
16.00
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
7 |
Net assets per share attributable to ordinary equity holders of the parent ($$) |
1.2900
|
1.9600
|
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
Country | Base Unit | Subunit |
Malaysia | Ringgit | Sen |
United States | Dollar | Cent |
United Kingdom | Pound | Pence |
Announcement Info
Company Name | PHARMANIAGA BERHAD |
Stock Name | PHARMA |
Date Announced | 20 Feb 2020 |
Category | Financial Results |
Reference Number | FRA-19022020-00012 |